Results 351 to 360 of about 2,029,665 (367)

Hepatocellular Carcinoma: New Developments.

Clinical Liver Disease, 2023
Previn Ganesan, L. Kulik
semanticscholar   +1 more source

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
J. Llovet, F. Castet, M. Heikenwalder, M. Maini, V. Mazzaferro, D. Pinato, E. Pikarsky, A. Zhu, R. Finn   +8 more
semanticscholar   +1 more source

Hepatocellular Carcinoma

Disease-a-Month, 2008
Willscott E, Naugler, Jonathan M, Schwartz   +1 more
openaire   +3 more sources

The Role of the IGF Axis in Hepatocarcinogenesis

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003
PD Dr. med, M. D. ·. J.-G.Scharf, Zentrum Innere, A. Medizin, Gastroenterologie Robert-Koch-Str, Göttingen. Germany, Hepatocellular Carcinoma   +6 more
semanticscholar   +1 more source

Evolving therapeutic landscape of advanced hepatocellular carcinoma

Nature reviews: Gastroenterology & hepatology, 2022
Chen Yang, Hailin Zhang, Linmeng Zhang, A. Zhu, R. Bernards, Wenxin Qin, Cun Wang   +6 more
semanticscholar   +1 more source

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

Nature Network Boston, 2022
A. Zhu, Alexander R. Abbas, Marina Ruiz de Galarreta, Y. Guan, Shan Lu, H. Koeppen, Wenjun Zhang, Chih-Hung Hsu, A. He, B. Ryoo, T. Yau, A. Kaseb, Adam M. Burgoyne, F. Dayyani, J. Spahn, W. Verret, R. Finn, H. Toh, A. Lujambio, Yulei N. Wang   +19 more
semanticscholar   +1 more source

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Journal of Hepatology, 2018
P. Galle, A. Forner, J. Llovet, V. Mazzaferro, F. Piscaglia, J. Raoul, P. Schirmacher, V. Vilgrain   +7 more
semanticscholar   +1 more source

Screening for hepatocellular carcinoma

Hepatology Research, 1999
This article reviews methodological issues around screening for hepatocellular carcinoma, and discusses selection of the at‐risk group, which screening test to use, and how frequently it should be applied. Screening of patients at risk for hepatocellular carcinoma should be undertaken using ultrasonography applied at six‐month intervals.
openaire   +6 more sources

Changing epidemiology of hepatocellular carcinoma in Asia

Liver international (Print), 2022
Chen-Hao Zhang, Yifei Cheng, Shu Zhang, Jia Fan, Q. Gao   +4 more
semanticscholar   +1 more source

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

Nature reviews: Gastroenterology & hepatology, 2021
J. Llovet, T. de Baère, L. Kulik, Philipp K. Haber, T. Greten, T. Meyer, R. Lencioni   +6 more
semanticscholar   +1 more source